BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  ACADIA Pharmaceuticals Presents Positive Top-line Results from Pivotal Phase 3 HARMONY Trial of Pimavanserin in Patients with Dementia-Related Psychosis at 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

  Pimavanserin met the primary endpoint in the study, significantly reducing the risk of relapse of psychosis by 2.8 fold (Hazard Ratio (HR)=0.353, one-sided p=0.0023)

  December 4, 2019

   · 

  12 min read
• Biotech Bay

  Ardelyx Announces Pricing of Upsized Public Offering of Common Stock

  The offering is expected to close on or about December 9, 2019, subject to customary closing conditions.

  December 4, 2019

   · 

  5 min read
• Policy

  American Lung Association Urges Smokers to ‘Quit, Don’t Switch’ to E-Cigarettes

  Lung Association Urges FDA to Crack Down on E-Cigarette Industry’s False Cessation Claims

  December 4, 2019

   · 

  4 min read
• BioCapital

  CORRECTING and REPLACING Nearly a Quarter of a Million Prescribers Using Surescripts Prescription Price Transparency Tool to View Patient Medication Cost Information

  In 2019, major progress was made in delivering price transparency to patients nationwide, with nearly 250,000 prescribers leveraging patient medication cost information when prescribing, according to the new Surescripts 2019 Impact Report: Prescription Price Transparency.

  December 4, 2019

   · 

  4 min read
• Business

  myNEXUS Announces Leadership Transition

  myNEXUS, a technology-driven care and benefit management platform, today announced Co-founder McArthur VanOsdale plans to step away from his day-to-day responsibilities as chief executive officer but will remain a member of the company’s board of directors.

  December 4, 2019

   · 

  2 min read
• Deals

  Canopy Biosciences Acquires Core Diagnostics

  Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for biopharmaceutical researchers

  December 4, 2019

   · 

  3 min read
• Business

  PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority

  PillTracker, an Israeli medication adherence start-up, announced today that it has joined the PMatX Innovation lab in Yavne, Israel, to accelerate the development of its innovative medication adherence solution.

  December 4, 2019

   · 

  2 min read
• Policy

  Information Update - Health Canada reminds Canadians of the dangers of unauthorized health products; it will not hesitate to take enforcement action if needed

  Health Canada would like to remind Canadians of the risks posed by unauthorized health products and to reaffirm that it will not hesitate to take action against illegal manufacturing and distribution of health products that could pose a health and safety risk to Canadians.

  December 4, 2019

   · 

  2 min read
• Business

  Progyny, Inc. Announces Third Quarter 2019 Results

  Reports 120% Increase in Third Quarter Revenue to $61.2 Million

  December 4, 2019

   · 

  27 min read
• BioMidwest

  Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference

  José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.

  December 4, 2019

   · 

  1 min read